WO2001077045A1 - Catalyse de reaction amelioree par apport d'energie et utilisations de ladite catalyse - Google Patents
Catalyse de reaction amelioree par apport d'energie et utilisations de ladite catalyse Download PDFInfo
- Publication number
- WO2001077045A1 WO2001077045A1 PCT/US2001/011703 US0111703W WO0177045A1 WO 2001077045 A1 WO2001077045 A1 WO 2001077045A1 US 0111703 W US0111703 W US 0111703W WO 0177045 A1 WO0177045 A1 WO 0177045A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- energy
- reaction
- electromagnetic
- molecules
- group
- Prior art date
Links
- 238000006243 chemical reaction Methods 0.000 title claims abstract description 165
- 238000006555 catalytic reaction Methods 0.000 title claims description 25
- 238000000034 method Methods 0.000 claims abstract description 47
- 230000002708 enhancing effect Effects 0.000 claims abstract description 18
- 230000001965 increasing effect Effects 0.000 claims abstract description 17
- 238000002965 ELISA Methods 0.000 claims abstract description 12
- 230000007704 transition Effects 0.000 claims description 26
- 238000003752 polymerase chain reaction Methods 0.000 claims description 7
- 238000003746 solid phase reaction Methods 0.000 claims description 5
- 239000007791 liquid phase Substances 0.000 claims description 4
- 230000027455 binding Effects 0.000 abstract description 10
- 239000011541 reaction mixture Substances 0.000 description 35
- 108020004414 DNA Proteins 0.000 description 32
- 239000000376 reactant Substances 0.000 description 27
- 239000000203 mixture Substances 0.000 description 21
- 238000010438 heat treatment Methods 0.000 description 20
- 239000003054 catalyst Substances 0.000 description 17
- 230000004913 activation Effects 0.000 description 14
- 229910052739 hydrogen Inorganic materials 0.000 description 14
- 230000001902 propagating effect Effects 0.000 description 14
- 108090000790 Enzymes Proteins 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 11
- 239000001257 hydrogen Substances 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 230000008859 change Effects 0.000 description 8
- 230000003321 amplification Effects 0.000 description 7
- 238000000137 annealing Methods 0.000 description 7
- 238000003199 nucleic acid amplification method Methods 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 238000004925 denaturation Methods 0.000 description 6
- 230000036425 denaturation Effects 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 230000009102 absorption Effects 0.000 description 5
- 230000004888 barrier function Effects 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 230000001678 irradiating effect Effects 0.000 description 5
- 230000005855 radiation Effects 0.000 description 5
- 108020003175 receptors Proteins 0.000 description 5
- 102000005962 receptors Human genes 0.000 description 5
- 102000053602 DNA Human genes 0.000 description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
- 108010006785 Taq Polymerase Proteins 0.000 description 4
- 238000005842 biochemical reaction Methods 0.000 description 4
- 239000005547 deoxyribonucleotide Substances 0.000 description 4
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical compound [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 description 4
- 229960004657 indocyanine green Drugs 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000035939 shock Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 108091006146 Channels Proteins 0.000 description 3
- 230000004544 DNA amplification Effects 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 208000036366 Sensation of pressure Diseases 0.000 description 3
- 229940035674 anesthetics Drugs 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 239000003193 general anesthetic agent Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000003589 local anesthetic agent Substances 0.000 description 3
- 229960005015 local anesthetics Drugs 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 230000001052 transient effect Effects 0.000 description 3
- 238000004566 IR spectroscopy Methods 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 102000018674 Sodium Channels Human genes 0.000 description 2
- 108010052164 Sodium Channels Proteins 0.000 description 2
- 239000011358 absorbing material Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000009790 rate-determining step (RDS) Methods 0.000 description 2
- 239000010979 ruby Substances 0.000 description 2
- 229910001750 ruby Inorganic materials 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 108020004491 Antisense DNA Proteins 0.000 description 1
- 102000034573 Channels Human genes 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000036982 action potential Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000003816 antisense DNA Substances 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 230000009137 competitive binding Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000001046 green dye Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000000608 laser ablation Methods 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008384 membrane barrier Effects 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 108020004084 membrane receptors Proteins 0.000 description 1
- 210000004088 microvessel Anatomy 0.000 description 1
- 238000003541 multi-stage reaction Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 238000006454 non catalyzed reaction Methods 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
- H05B6/00—Heating by electric, magnetic or electromagnetic fields
- H05B6/64—Heating using microwaves
- H05B6/80—Apparatus for specific applications
- H05B6/806—Apparatus for specific applications for laboratory use
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0093—Microreactors, e.g. miniaturised or microfabricated reactors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
- B01J19/12—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor employing electromagnetic waves
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
- B01J19/12—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor employing electromagnetic waves
- B01J19/121—Coherent waves, e.g. laser beams
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
- B01J19/12—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor employing electromagnetic waves
- B01J19/122—Incoherent waves
- B01J19/126—Microwaves
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
- B01J19/12—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor employing electromagnetic waves
- B01J19/122—Incoherent waves
- B01J19/129—Radiofrequency
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J3/00—Processes of utilising sub-atmospheric or super-atmospheric pressure to effect chemical or physical change of matter; Apparatus therefor
- B01J3/06—Processes using ultra-high pressure, e.g. for the formation of diamonds; Apparatus therefor, e.g. moulds or dies
- B01J3/08—Application of shock waves for chemical reactions or for modifying the crystal structure of substances
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L7/00—Heating or cooling apparatus; Heat insulating devices
- B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00781—Aspects relating to microreactors
- B01J2219/00873—Heat exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00781—Aspects relating to microreactors
- B01J2219/00889—Mixing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00781—Aspects relating to microreactors
- B01J2219/00925—Irradiation
- B01J2219/00932—Sonic or ultrasonic vibrations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00781—Aspects relating to microreactors
- B01J2219/00925—Irradiation
- B01J2219/00934—Electromagnetic waves
- B01J2219/00941—Microwaves
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00781—Aspects relating to microreactors
- B01J2219/00925—Irradiation
- B01J2219/00934—Electromagnetic waves
- B01J2219/00948—Radiofrequency
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
- B01J2219/0873—Materials to be treated
- B01J2219/0877—Liquid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
- B01J2219/0873—Materials to be treated
- B01J2219/0879—Solid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
- B01J2219/0873—Materials to be treated
- B01J2219/0892—Materials to be treated involving catalytically active material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/18—Means for temperature control
- B01L2300/1861—Means for temperature control using radiation
Definitions
- the present invention relates generally to the fields of biochemical reaction and biomedical physics. More specifically, the present invention relates to methods/devices used for enhancing catalytic chemical reaction by adding energy to th e reactants therefore to increase the frequency at which reactants reach transition states of reaction.
- Activation Energy and Reaction Rates In any given chemical reaction, the equilibrium of the reaction is given by th e difference in ⁇ G° for the reaction. The equilibrium concentrations of substrate (A) and product (C) are determined by their difference in free-energy content,
- a catalyst lowers th e activation energy of the rate determining steps, thereby speeding up the reaction.
- the role of the catalyst is to permit the formation of a transition state of lower energy (higher stability relative to reactants) than that for non-catalyzed reactions.
- the catalyst itself does not participate in the reaction stoichiometry (not consumed) and cannot affect the equilibrium position of th e reaction. Pauling expressed that stabilization of the transition state of a reaction by an enzyme suggests that the enzyme has a higher affinity for the transition state than it does for th e substrate or products. ⁇ G' therefore, is reduced during catalysis.
- the polymerase chain reaction is a technique used for in vitro and in situ amplification of specific DNA sequences.
- the process goes in receptive cycles: denaturing, wherein the DNA of interest is denatured for about 4 minutes a t 94°C; annealing, wherein the appropriate part of the DNA strands are annealed to the primers (i.e., the antisense DNA fragment o f interest) at 50°C for about 2 minutes; and extension, wherein a heat stable enzyme called Taq-DNA-polymerase (Taq) polymerizes the individual DNA bases (deoxyribonucleotides) for 3 minutes at 72°C.
- Taq heat stable enzyme
- Such cycle is repeated for N times (-20- 30 times) with more primers and nucleotides added.
- heating parameters may be modified slightly (for example, denaturing for lmin. at 94°C; annealing for 2 min . at 50°C; and extending for 3.5 min at 72°C).
- th e heating parameters for the last cycle are also typically different, for example, denaturing for lmin. at 94°C; annealing for 2 min. a t 50°C; and extending for 10 min at 72°C.
- the DNA o f interest is amplified by 2 N .
- Biochemical Reaction Catalysis In order to undergo a chemical reaction, a reactant or reactants must first gain energy (activation energy) to form an activated complex before they c an proceed forward to a state (products) of different energy o r enthalpy. Generally, enzymes are used to help the reaction take place (i.e. catalyze the reaction). Heat can also be used to speed up the reaction rate. Additionally, vibrational excitation can b e used to promote endoergic (energy consuming) reactions [1].
- the prior art is deficient in the lack of effective means of enhancing reaction catalysis by adding energy to the reactants .
- the present invention fulfills this long-standing need and desire in the art.
- the present invention provides methods of enhancing reaction catalysis by adding energy to reactants.
- th e present invention provides a method of using electromagnetic energy or propagating pressure waves to enhance reaction, wherein vibrations, rotations, and/or particular configurations o r orientations of the reactants are induced. When done properly, these methods do not cause irreversible damage to the reactants and are especially suitable for use in biochemical reactions b o th in vitro and in vivo.
- the electromagnetic energy is generated by a source which provides radiant energy with wavelength from about 200 nm to about 20,000 nm.
- Representative examples o f electromagnetic energy include radiofrequency wave and microwave, and representative example of mechanical energy is a pressure wave.
- the chemical reaction is a catalyzed reaction, it can be either a liquid-phase reaction or a solid-phase reaction.
- a device for accelerating a chemical reaction comprising a reaction chamber; and a means for applying energy to the reaction chamber.
- a method of enhancing a polymerase chain reaction by applying energy to the reaction is provided.
- Such method c an also be used for enhancing an enzyme linked immunoassay reaction.
- a device for enhancing a polymerase chain reaction comprising a reaction chamber; and a means for applying energy to the reaction chamber.
- Such device can also b e used for enhancing an enzyme linked immunoassay reaction.
- a method of increasing the rate a t which a group of molecules reaches a different molecular configuration from initial configuration comprising the step o f applying energy to the molecules.
- the energy is electromagnetic energy or mechanical energy.
- Representative examples of electromagnetic energy include radiofrequency wave and microwave, and representative example of mechanical energy is a pressure wave.
- the different molecular configuration is a transition state in a chemical reaction, preferably, a catalyzed chemical reaction.
- a device for increasing the rate at which a group of molecules reaches a different molecular configuration from initial configuration comprising a chamber for holding the molecules; and a means for applying energy to the chamber.
- Figure 1 shows reaction coordinates as a function o f the free energy.
- the free energy of activation, ⁇ G' is the energy that must be overcome for the reaction to proceed.
- Figure 2 shows reaction coordinates as a function of the free energy in the presence of a catalyst.
- the free energy o f activation, ⁇ G', is much smaller compared to that without the catalyst (see Figure 1).
- Figure 3 shows reaction coordinates as a function of the free energy in the presence of an enzyme.
- the free energy o f activation, ⁇ G' is broken into smaller increments by the step wise action of the enzyme catalyst which first forms an enzyme- substrate complex (i.e., ES), reaches the intermediate transition state (1), and the intermediate transition state (2), and finally proceeds to the subsequent product.
- ES enzyme- substrate complex
- Figure 4A shows a kind of device used for enhancing a PCR reaction.
- Such device comprises a radiant energy source for heating the reaction; a microvessel containing the reactants ; and a cooling chamber.
- a catalyst can be included.
- the vessel alternates between heating and cooling cycles allowing standard PCR reaction to proceed.
- an optional reaction chamber without the energy absorbing target/transducer, may be used to directly delivery energy to th e reactants for either local heating or for increasing the energy state of the reactants thereby increasing the frequency at which the reactants reach transition state.
- the device 1 shown in Figure 4A comprises pulsed laser source 2 to generate a laser beam, expanding/focusing optics 3 , radiant energy absorbing target/transducer 4 to transduce propagating pres sure waves, a reaction chamber 5 containing reaction mixture and stir bars 6 , and heater/cooler 7.
- Figures 4B-4E show that different shaped radiant energy absorbing targets within the walls of th e reaction chamber 5 , or inside the reaction solution, produc e different pressure waves.
- Figure 5 is an energy diagram demonstrating alternating cycles of radiant energy for multi-step reactions su ch as the optically enhanced PCR.
- Energy reaching level (2) is sufficient to separate the strands of DNA.
- the energy is then reduced to a lower level (1) that favors a second reaction in th e sequence by catalysis.
- Level (1) is not great enough to denature the molecular products. This cycle is repeated to produce long strands of DNA.
- the present invention describes a device composed o f a reaction vessel where radiant energy may be supplied in such a way that reactants within the vessel are exposed to a free energy increase in the system which causes increased vibration o r rotation in molecular groupings, or causes electrons to shift t o excited states making the molecules more reactive.
- a catalyst present in or attached to the reaction vessel in such a way th at the reactants are in contact with the catalyst, will then be in position to stabilize transition states of the reactants, thereby improving the chances that the reaction will proceed forward.
- the reaction vessel may contain at least one reactant and one enzyme that reacts in a step-wise manner to generate products.
- Radiant energy of a certain wavelength and energy is delivered to the reaction vessel in such a way that the reactants are activated so the first step catalytic reaction proceeds at a faster pace.
- a second wavelength, and/or energy is then applied to the reaction such that a second step, which requires a different energy of activation, can then take place.
- steps may b e repeated for cyclic reactions.
- a sample o f chromosomal or other DNA is present in the reaction chamber with an oligonucleotide primer and the catalyst.
- the first step laser radiation is added to the chamber to increase the energy o f the reaction such that the strands of the DNA are denatured and separated either locally or for the greater length of the molecule.
- the laser energy is removed, either completely or in between pulses, the strands of DNA will then re-anneal.
- the primer will compete for binding sites to the strand of denatured DNA. If the primer is in excess relative to the concentration of the sister DNA strand, more primer will bind as opposed to strands re-annealing.
- radiant energy is provided t o an enzyme catalyzed reaction mixture such that energy, in th e form of heat, is delivered locally in the immediate environment o f the molecule, thereby resulting in thermal acceleration of th e rate of reaction.
- This local heating effect is only transient, on th e order of less than microseconds, in the case of a pulsed laser. However, it is of sufficient length to result in an increase in th e frequency at which these molecules reach their transition state. In the presence of a catalyst, this transition state is stabilized and the reaction proceeds. Specifically, the use of short, high-energy pulses of radiant energy results in little heating of th e surrounding medium.
- the electromagnetic energy is generated by a source which provides radiant energy with wavelength from about 200 nm to about 20,000 nm.
- Representative examples o f electromagnetic energy include radiofrequency wave and microwave, and representative example of mechanical energy is a pressure wave.
- the chemical reaction is a catalyzed reaction, it can be either a liquid-phase reaction or a solid-phase reaction.
- a device for accelerating a chemical reaction comprising a reaction chamber; and a means for applying energy to the reaction chamber.
- a method of enhancing a polymerase chain reaction by applying energy to the reaction is provided.
- Such method c an also be used for enhancing an enzyme linked immunoassay reaction.
- a device for enhancing a polymerase chain reaction comprising a reaction chamber; and a means for applying energy to the reaction chamber.
- Such device can also b e used for enhancing an enzyme linked immunoassay reaction.
- the energy is electromagnetic energy or mechanical energy.
- electromagnetic energy include radiofrequency wave and microwave
- mechanical energy is a pressure wave.
- the different molecular configuration is a transition state in a chemical reaction, preferably, a catalyzed chemical reaction.
- a device for increasing the rate at which a group of molecules reaches a different molecular configuration from initial configuration comprising a chamber for holding th e molecules; and a means for applying energy to the chamber.
- Enzymatic catalysts are believed to lower ⁇ G' by replacing a single step of large ⁇ G' with several smaller steps o f lower ⁇ G' ( Figure 3).
- enzyme mediated catalysis is extremely efficient for reactions with large ⁇ G' because each incremental step is composed of a smaller transition energy o f activation.
- the step wise transitions may be taken advantage of and the undesirable reactions and denaturation avoided.
- a continuous wave or pulsed laser is used to heat the surrounding medium rapidly in such a way th at the heat involved in the reaction increases rapidly.
- a small reaction volume can then be cooled rapidly so that unstable products or side reactions are minimized.
- This approach is particularly useful when cyclic reactions are necessary, wherein rapid heating and cooling steps may take place in relatively small volumes.
- Energy may also be added to the system using microwaves or radiofrequency waves in the same manner .
- Radiofrequency waves are of particular interest because they are capable of causing the vibrational effects in the medium without heating of the applicator. In effect, radiofrequency waves may b e incorporated into a heating element that does not heat up the element itself during use.
- the heating element could always be kept cold while it transmits energy to the reaction medium in direct contact with or near to it.
- short and repeated pulses of radiant energy are directed at the molecular species which causes a n increased level of excitation.
- This approach takes advantage o f the fact that molecular species absorb photonic energy, which increases their intrinsic rate of rotation or vibration and th e likelihood that inner shell electrons will be promoted to outer shells, thereby creating a less stable structure.
- the above described methods can also be used for improving reaction rates in solid-phase reactions.
- a method/device is hereby provided to increase th e speed and efficiency of PCR. Such method/device may also increase the yield of PCR products and reduce the amount o f reactants used by virtue of minimizing or eliminating heating o f the PCR reaction solution. Reducing or eliminating the heat involved in denaturation also reduces or eliminates the need for thermostable enzymes. Strategies described within include activating molecules or molecular groups through energy absorption from infrared radiation. Absorption of infrared radiation by biomolecules can be broken down into three regions.
- an OH group stretching vibration is near 7140 cm” 1 (1.4 microns) and an NH stretching vibration is near 6667 cm 1 (1.5 microns).
- 4000 to 1300 cm “ 1 (2.5-7.7 microns) is the "group frequency region"
- 1300 to 650 cm 1 (7.7-15.4 microns) is the "fingerprint region”.
- Absorptions depend on the functional group present (in the case of the former) and not the complete molecular structure, or depend on single-bond stretching and bending vibrations (in the case of the latter).
- Denaturation of DNA can be achieved using radiative energy [2].
- Radiant energy with a wavenumber of about 1550- 1800 cm 1 induces in-plane double-bond vibrations of bases, with a wavenumber of about 1275- 1550 cm " 1 induces base deformation motions coupled through glycosidic linkages t o sugar vibrations, with a wavenumber of about 1050- 1275 cm 1 induces phosphate and sugar vibrations, and with a wavenumber of about 750-1050 cm 1 induces vibrations of the sugar- phosphate backbone and bases. All of these infrared spectral domains are in the infrared region of the electromagnetic spectrum (wavelengths of about 5.5-12.5 microns).
- the 1225 cm '1 and 1084 cm - 1 (asymmetric and symmetric stretching vibrations o f nucleic acids) bands could be targeted by lasers emitting long- wavelength radiant energy; in the case of the former, a CO 2 laser would suffice.
- DNA has hydrogen bonds between the two strands .
- hydrogen bonds For every adenine and thymine base, there are two hydrogen bonds, viz.: O- - -H and N - H.
- the ionic OH and NH bonds have energies on the order of 111 and 9 3 kcal/mol respectively, while the O- - -H and N - H hydrogen bonds have energy on the order of about 1 kcal/mol, which is why they are easily broken.
- One method of breaking hydrogen bonds is by continued exposure to temperatures on the order o f 75°C.
- hydrogen bonds can be broken by radiant energy photons with a wavelength of about 32 microns or less.
- the ionic OH and NH bonds require photons with wavelengths of about 307 nm or less. Consequently, one c an break hydrogen bonds in DNA without causing breaks in the DNA strands themselves (i.e.
- the OH stretching vibration near 1.4 microns and the NH stretching vibration near 1.5 microns could be excited with radiant energy produced by, for example, an Nd:YLF or Nd: glass laser.
- radiant energy produced by, for example, an Nd:YLF or Nd: glass laser.
- irradiating the DNA with 1.4-1.5 micron radiant energy prior to the hydrogen-bond-breaking step done with radiant energy at a longer wavelength would increase the reaction rate.
- by irradiating the denatured DNA with 1 .4- 1 .5 micron radiant energy after the denaturation step would increase the reaction rates of the annealing and extension step.
- different wavelengths may be used to differentially o r combinatorially enhance the conversion of species from one t o another.
- Compressional or tensile propagating pressure waves can be produced by irradiating biological media with pressure waves produced by acoustic transducers (such a s piezoelectric crystals or ultrasonic transducers) or radiant energy produced by a pulsed laser, or by irradiating absorbing materials placed in intimate acoustic contact with tissue of interest.
- Shock waves propagating pressure waves moving in a medium a t velocities greater than the speed of sound in the medium
- a propagating pressure wave can transform into a shock wave within a short distance while propagating in water, for example.
- a pressure wave with an amplitude of 300 bars can provide about 0.72 kcal/mol of energy. This is sufficient to break hydrogen bonds, but not enough to break covalent or ionic bonds.
- the ability to break bonds and induce vibrations results from not only the amplitude of the wave, b u t also the temporal characteristics. Further, the addition of a n appropriate catalyst to any of these enhanced reactions would favor stabilization of transition molecules and therefore further increase the forward reaction rate.
- FIG. 4A When propagating pressure waves are produced b y pulsed laser radiant energy impinging on an absorbing target ( Figure 4A), different shaped targets may be beneficial ( Figures 4B-4E). For example, different shaped targets within the walls o f the reaction chamber, or inside the reaction solution, c an produce pressure waves that can be beneficial. Multiple lasers can also be used to produce multiple propagating pressure waves impinging on the reaction mixture from different directions. It is beneficial to continually mix the reaction mixture and place th e reaction chamber on a controllable heating/cooling element t o maintain the temperature of the reaction solution in a region suitable for the process to take place.
- reaction mixture it can be beneficial to de-gas the reaction mixture, or introduce hyperbaric inert gases (e.g. N 2 ) in the reaction mixture, so as to maintain a sealed reaction vessel in order to modulate the extent to which cavitation bubbles are produced.
- hyperbaric inert gases e.g. N 2
- these bubbles propagate and carry significant amounts of energy to damage biological media, such as DNA.
- they may b e used to beneficially add energy to the reaction mixture.
- pulsed or continuous wave radiant energy c an be used to directly excite molecules to which light-absorbing complexes are attached.
- energy can be added to the reactants by transference from these dye-conjugates molecules or simply by the dye itself upon the absorption of a pulse of radiant energy from, for example, an alexandrite laser tuned to emit energy with a wavelength of 795 nm.
- a pulse of radiant energy from, for example, an alexandrite laser tuned to emit energy with a wavelength of 795 nm.
- Catalytic reactions often rely on specific interactions among various reactants or between the catalyst and reactants .
- the shape and/or size of molecules can sometimes determine where the molecule has an affinity to localize and bind.
- a particular protein can interact with a particular target molecule when the protein is folded into it's "native" state; when unfolded, or denatured, it typically cannot interact with th e target molecule in spite of the fact that the protein still has the same peptide sequence.
- the particular desirable (or deleterious) protein- protein, protein-DNA or protein-molecule interaction depends o n the correct binding of the molecules.
- the efficiency of binding o r reacting can be increased by increasing the rate at which th e molecules "bump" into each other. This is typically a function o f concentration and kinetic energy in the system.
- binding or reacting can be altered by a change in conformation o f one or both of the molecules.
- a conformational change may increase the exposure of the binding sites on each molecule o r may alter the shape of each molecule such that they c an approach each other more closely. For example, it is generally accepted that blocking the flow of sodium through the sodium channel in nerve cell membranes makes the nerve inexcitable by local action currents.
- Changes in the shape and caliber of this channel determines what anesthetics are efficacious.
- the shape and caliber of the channel can be changed by, for example, action potentials, toxins, and local anesthetics that bind to gating receptor sites. Some local anesthetics bind to a channel protein binding site thus rendering the sodium channel blocked.
- Transport of molecules across membranes or o ther tissue barriers may be enhanced through application of th e concepts described herein.
- irradiation of a membrane or the skin will result in transient changes in the molecular configuration of its constituents. Molecules which come into contact with the irradiated molecules will have a n accelerated rate of binding or reacting as compared to those in non-irradiated tissue.
- This concept may be applied to drug permeation through membranes or tissue barriers.
- one of the rate limiting steps in permeation of compounds through membranes or tissue barriers is the rate of initial binding to local receptors.
- anesthetics such as lidocaine
- permeation is in part related to the rate of local binding to receptors.
- a reaction involving test molecules is enhanced by transiently and repetitively raising th e temperature of the surrounding environment (i.e. the ambient molecules) .
- PCR reaction A PCR mixture including buffers, primers, Taq polymerase and deoxyribonucleotides was prepared as per manufacturer' s instructions and placed in a reaction vial. Equal amount of a sample of DNA to be amplified was added t o the mixture. The reaction mixture was exposed to the radiant energy produced by a Ho:YAG laser. The laser radiant energy output was configured to produce a spot size at the reaction vial of 5 mm, with a 400 microsecond pulse, 10 Hz pulse repetition rate, and 200 mJ/pulse pulse energy. The radiant energy, which was absorbed by the reaction mixtures, was arranged to impinge on the lateral side of the reaction vial in a position so that the reaction mixture was irradiated.
- ELISA An enzyme linked immunoassay (ELISA) reaction mixture was prepared in 96-well plates previously seeded with equal numbers of rat cancer cells. The reaction mixture was MTT, which produces a colorimetric change in th e presence of viable cells. After adding the assay reaction mixture to the wells in the plate, single wells were irradiated with the radiant energy produced by a Ho:YAG laser.
- the laser radiant energy output which was absorbed by the reaction mixtures, was configured to produce a spot size at the surface of the reaction mixture of 5 mm, with a 400 microsecond pulse, 10 Hz pulse repetition rate, and 200 mJ/pulse pulse energy.
- the irradiation continued on for a period of 10 minutes, after which a solvent was added and the mixture was spectroscopically assayed for color.
- the result shows that a greater degree of color change (in other words, a greater optical density OD) occurred in th e irradiated mixture as compared to controls. Since the wells were seeded with equal numbers of cells, the greater OD is indicative of an enhanced reaction catalysis and not of different numbers o f viable cells.
- an ELISA reaction mixture was prepared in 96-well plates previously seeded with equal numbers of ra t cancer cells.
- the reaction mixture was MTT, which produces a colorimetric change in the presence of viable cells.
- entire 96-well plate was exposed to microwave energy by placing the plate within a 500 Watt microwave oven.
- the microwave irradation conditions were as follows: the oven was set to the defrost mo de (lowest power possible) and the oven was sequenced on and off repetitively (approximately 2 seconds on and 10 seconds off) fo r a period of 10 minutes. After the irradiation, a solvent was added and the mixture was spectroscopically assayed for color.
- reaction mixture a reaction involving te s t molecules is enhanced by transiently and repetitively raising th e temperature of an absorbing species added to the surrounding environment (reaction mixture).
- a PCR mixture was prepared as per manufacturer' s instructions and placed in a reaction vial. Equal amount of a sample of DNA to be amplified was added to the mixture. The enzyme present in the reaction mixture was Taq polymerase. The reaction mixture was exposed to the radiant energy produced by a ruby laser. The laser radiant energy output was configured t o produce a spot size at the reaction vial of 5 mm, with a 400 microsecond pulse, 10 Hz pulse repetition rate, and 200 mJ/pulse pulse energy. Indocyanine green (ICG) was solubilized in ultrapure water and added to the reaction mixture to a final concentration of 1%.
- ICG Indocyanine green
- the radiant energy which was absorbed primarily by the ICG, was arranged to impinge on the lateral side of the reaction vial in a position so that the reaction mixture was irradiated.
- the irradiation continued on for a period of 2 0 minutes, after which the mixture was assayed for DNA amplification.
- the degree of amplification was compared to non- irradiated (control) samples. The result shows that greater amplification occurred in the irradiated mixture as compared t o controls .
- a PCR mixture including buffers, primers, Taq polymerase and deoxyribonucleotides was prepared as p e r manufacturer' s instructions and placed in 0.1 mm pathlength optical cuvettes. Equal amount of a sample of DNA to b e amplified was added to the mixture. The reaction mixture was exposed to the radiant energy produced by an Nd:YLF laser. The laser radiant energy output was configured to produce a spot size at the lateral side of the cuvette of 5 mm, with a 400 microsecond pulse, 10 Hz pulse repetition rate, and 20 mJ/pulse pulse energy.
- a reaction involving test molecules is enhanced by transiently and repetitively exposing the test molecules and reaction mixture to propagating pres sure waves.
- a PCR mixture including buffers, primers, Taq, o r other DNA polymerase, and deoxyribonucleotides was prepared as per manufacturer' s instructions and placed in a reaction cuvette. Equal amount of a sample of DNA to be amplified was added to the mixture.
- a Q-switched or mode-locked laser e.g. , ruby or Nd:YAG
- a 20 ns pulse duration, 1 mm spot size, 1 0 Hz pulse repetition rate and 20 mJ pulse energy was directed on a light absorbing material (e.g. thermoelectrically cooled black anodized aluminum) in intimate acoustic contact with th e reaction cuvette.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Electromagnetism (AREA)
- Toxicology (AREA)
- Clinical Laboratory Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Optics & Photonics (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
Abstract
L'invention concerne un procédé/dispositif (1) permettant d'améliorer une réaction chimique notamment PCR et ELISA par utilisation d'énergie électromagnétique ou mécanique. On peut également utiliser ce procédé/dispositif (1) pour augmenter la vitesse à laquelle un groupe de molécules induit une configuration moléculaire différente de la configuration initiale, ce qui permet d'accélérer la liaison et la réaction desdites molécules.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001251521A AU2001251521A1 (en) | 2000-04-10 | 2001-04-10 | Energy enhanced reaction catalysis and uses thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/546,065 | 2000-04-10 | ||
US09/546,065 US6673214B1 (en) | 1999-04-09 | 2000-04-10 | Energy enhanced reaction catalysis and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001077045A1 true WO2001077045A1 (fr) | 2001-10-18 |
Family
ID=24178711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/011703 WO2001077045A1 (fr) | 2000-04-10 | 2001-04-10 | Catalyse de reaction amelioree par apport d'energie et utilisations de ladite catalyse |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001251521A1 (fr) |
WO (1) | WO2001077045A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002008455A3 (fr) * | 2000-07-25 | 2002-08-15 | Biotix Gmbh | Procede de separation d'acides nucleiques a brin double se trouvant dans une solution, en acides nucleiques a un seul brin |
WO2022020955A1 (fr) * | 2020-07-31 | 2022-02-03 | 12198703 Canada Ltd. | Cinétique chimique à orientation dirigée |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5689008A (en) * | 1996-02-02 | 1997-11-18 | United Technologies Corporation | Catalytic reaction rate enhancement at low temperatures |
WO1998006876A1 (fr) * | 1996-08-16 | 1998-02-19 | Pharmacia Biotech Inc. | Dispositif et procedes destines a une conversion thermique par un transducteur induite a distance dans des reactions chimiques et biochimiques |
-
2001
- 2001-04-10 AU AU2001251521A patent/AU2001251521A1/en not_active Abandoned
- 2001-04-10 WO PCT/US2001/011703 patent/WO2001077045A1/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5689008A (en) * | 1996-02-02 | 1997-11-18 | United Technologies Corporation | Catalytic reaction rate enhancement at low temperatures |
WO1998006876A1 (fr) * | 1996-08-16 | 1998-02-19 | Pharmacia Biotech Inc. | Dispositif et procedes destines a une conversion thermique par un transducteur induite a distance dans des reactions chimiques et biochimiques |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002008455A3 (fr) * | 2000-07-25 | 2002-08-15 | Biotix Gmbh | Procede de separation d'acides nucleiques a brin double se trouvant dans une solution, en acides nucleiques a un seul brin |
WO2022020955A1 (fr) * | 2020-07-31 | 2022-02-03 | 12198703 Canada Ltd. | Cinétique chimique à orientation dirigée |
US12151224B2 (en) | 2020-07-31 | 2024-11-26 | 12198703 Canada Ltd. | Directed orientation chemical kinetics |
Also Published As
Publication number | Publication date |
---|---|
AU2001251521A1 (en) | 2001-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6673214B1 (en) | Energy enhanced reaction catalysis and uses thereof | |
JP6475645B2 (ja) | 核酸の増幅のための方法 | |
US8263005B2 (en) | Methods and systems for modulating acoustic energy delivery | |
US6573491B1 (en) | Electromagnetic energy driven separation methods | |
US6484052B1 (en) | Optically generated ultrasound for enhanced drug delivery | |
US7981368B2 (en) | Method and apparatus for acoustically controlling liquid solutions in microfluidic devices | |
US20040129555A1 (en) | Energy enhanced reaction catalysis and uses thereof | |
US5972667A (en) | Method and apparatus for activating a thermo-enzyme reaction with electromagnetic energy | |
US20040229295A1 (en) | Activated delivery of biomolecules using electromagnetic energy | |
Moon et al. | Plasmonic nanobubbles–a perspective | |
Canaparo et al. | The bright side of sound: Perspectives on the biomedical application of sonoluminescence | |
WO2012144916A2 (fr) | Dispositif pour l'administration efficace de composés à ou à travers la peau ou des barrières biologiques, à l'aide de couches minces absorbant la lumière | |
WO2001077045A1 (fr) | Catalyse de reaction amelioree par apport d'energie et utilisations de ladite catalyse | |
US8008069B2 (en) | Apparatus and method for machining microchamber for cell culture | |
Oraevsky et al. | Pulsed laser ablation of biological tissue: Review of the mechanisms | |
WO2000010679A1 (fr) | Elimination de la mousse | |
US20030196885A1 (en) | Electromagnetic energy driven separation methods | |
Boni et al. | High-power laser applications to medicine | |
Ogura et al. | In vivo targeted gene transfer by direct irradiation with nanosecond pulsed laser | |
Letokhov | Laser light in biomedicine and the life sciences: From the present to the future | |
Lester | VIBRATIONAL RELAXATION DYNAMICS IN BULK GASES AND SUPERSONIC MOLECULAR BEAMS. | |
Bagratashvili et al. | An EPR and optical spectroscopy study of the effect of laser radiation on biological tissues | |
Kıdak | Sources of dissipation: An outlook into the effects of operational conditions | |
Khosroshahi et al. | A preliminary analysis of drug delivery using a super long chopped-pulse CO 2 laser | |
Zharov | Application of optoacoustic spectroscopy in biomedicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |